article thumbnail

The thorniest questions facing pharma, according to a leading bioethicist


Bioethics guru Arthur Caplan of NYU gives his outspoken and frank opinion on the industry’s minefield of ethical challenges.

Bioethics 246
article thumbnail

STAT+: Venture capitalists want to own hospitals. Can they do better than private equity?


Given workforce shortages, clinician burnout, rising drug costs, and a surging aging population, “it’s not that big a leap to say that more such purchases are going to occur,” said Robert Klitzman, a Columbia psychiatry professor and director of its bioethics masters program.

Hospitals 341

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Bioethics International reveals index to score pharma on trial diversity

Outsourcing Pharma

The not-for-profit organization published its fair inclusion score to measure and rank pharmaceutical companies on their inclusion of women, older adults, and racial and ethnic minoritized patients.

article thumbnail

STAT+: Foundation charges cancer patients $83,000 for unproven but promising experimental drug


”It’s imprudent and unwise and not the way forward, even for people who are very ill,” said Dr. Arthur Caplan, a professor of bioethics at the NYU Langone hospital system in New York who chaired a university panel that studied the FDA’s compassionate use program.

Vaccines 246
article thumbnail

Bayer Pharmaceuticals accelerates innovations for patients


Bayer works on leveraging all the possibilities of the technologies while fully integrating all regulatory and bioethical requirements.” ” [link] The post Bayer Pharmaceuticals accelerates innovations for patients appeared first on LifeProNow.

Bioethics 130
article thumbnail

Study shows there is still a long way to go on trial diversity


Bioethics International has developed a benchmarking tool for “fair inclusion” in clinical trials, drawing on pivotal trials submitted to the FDA in support of 59 new cancer therapeutics – submitted by 25 sponsors – that were approved by the regulator between 2012 and 2017.

article thumbnail

NHC Comments on Notice of Proposed Rulemaking on Discrimination on the Basis of Disability in Health and Human Service Programs or Activities

Putting Patients First Blog

Medical futility and disability bias: part of the bioethics and disability series. Retrieved from https ://w d d/disabilityandhealth/infographic-disability-impacts-all.html 14 National Council on Disability. National Council on Disability. link] 15 FitzGerald, C. and Hurst, S.